HeartBeam makes a pocket-sized ECG device that lets patients record heart signals outside a hospital and sends them to doctors via a smartphone app and cloud software.
No revenue is reported; the company has posted operating losses of USD -0.02B in each of the last two fiscal years, so it currently has no paying business.
No visible moat: the device faces direct competition from established cardiac monitoring players like AliveCor and Philips, and with no revenue or proprietary network effects, customers can easily switch to those alternatives.
Key events, in time order
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
